The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.
April 23rd 2024
In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Revolutionizing Early-Stage NSCLC Treatment: Pathologists’ Key Insights into Predicting Pathologic Responses to Immunotherapies
View More
Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs
View More
Medical Crossfire®: Expert Exchanges to Maximize Clinical Outcomes for Patients with CRPC Through Evidence-Based Personalized Therapy
View More
23rd Annual International Congress on the Future of Breast Cancer® West
July 12-13, 2024
Register Now!
25th Annual International Lung Cancer Congress®
July 25-27, 2024
Register Now!
2023 ASCO Direct™ Highlights: Practice-Changing Data From the Leading Oncology Conference
View More
6th Annual Precision Medicine Symposium: An Illustrated Tumor Board
October 18-19, 2024
Register Now!
Community Practice Connections™: 24th Annual International Lung Cancer Congress®
View More
19th Annual New York Lung Cancers Symposium®
November 16, 2024
Register Now!
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: How Do the Experts Select and Sequence Therapies to Optimize Patient Outcomes and Quality of Life in Advanced Prostate Cancer?
View More
Lung Cancer Tumor Board®: Enhancing Multidisciplinary Communication to Optimize Immunotherapy in Stage I-III NSCLC
View More
Clinical Vignettes™: The Experts Explain How They Integrate PET Imaging into Metastatic HR+ Breast Cancer Care Settings
View More
School of Breast Oncology® Live Video Webcast: Clinical Updates from San Antonio
View More
Community Practice Connections™: The 2nd Annual Hawaii Lung Cancers Conference®
View More
Judy Yee, MD, FACR Receives Gold Medal Honors from the Society of Abdominal Radiology
August 24th 2022Well known for her education and advocacy on the use of computed tomography (CT) colonography for colorectal cancer screening, Dr. Yee is also widely recognized for her leadership, mentoring skills and being a champion for diversity in the field of radiology.
MRI/CT Imaging for Axillary Lymph Nodes: What a New Breast Cancer Study Reveals
August 16th 2022The combination of magnetic resonance imaging (MRI) and computed tomography (CT) had a 63.83 percent sensitivity rate for tumor-infiltrated axillary lymph nodes in patients with breast cancer in comparison to a 36.11 percent sensitivity rate for the combination of mammography and sonography.
Lung Cancer Screening Study Says Significant Disparities Persist Despite Expanded Eligibility
August 9th 2022While recent recommendations from the United States Preventive Services Task Force (USPSTF) to lower lung cancer screening thresholds significantly expanded eligibility for screening tests such as low-dose computed tomography (CT), differences in education, health-care insurance and proximity to health-care facilities continue to be key drivers of racial and socioeconomic disparities limiting access to appropriate preventive care.
Can EHR Interventions Have an Impact in Conserving Iodinated Contrast Media in Radiology?
August 3rd 2022A recent study found the use of an alert and a request for more clinical information in a multisite health system’s electronic health record (EHR) system led to a 12 percent reduction in contrast-enhanced computed tomography (CT) exams per day and a 15.2 percent reduction in orders for CT with contrast media per day.
Study Suggests AI Enhances Non-Contrast CT Detection of Large Vessel Occlusion
July 29th 2022Artificial intelligence (AI) accurately diagnosed 79 percent of proximal large vessel occlusions with an ipsiversive gaze deviation on non-contrast computed tomography (CT), according to new research findings presented recently at the Society of Neurointerventional Surgery’s (SNIS) 19th Annual Meeting in Toronto.
What's Next in Medical Image and Data Management in Radiology?
July 20th 2022In a video interview, Morris Panner, the president of Intelerad Medical Systems, discussed key observations from the recent Society for Imaging Informatics in Medicine (SIIM) conference, recent research about artificial intelligence (AI) adoption and emerging goals for enhancing the efficiency of radiology workflows.
Iodinated Contrast Media Alternative: FDA OKs Bayer Importing Foreign-Labeled Iopromide
July 19th 2022The Food and Drug Administration (FDA) has given the green light to Bayer to import foreign-labeled iopromide (Ultravist) to help alleviate ongoing supply challenges with iodinated contrast media in the United States.
Study Suggests Benefits of Preoperative CT for Left Atrial Appendage Occlusion Procedures
July 14th 2022Emerging research shows the use of preoperative computed tomography (CT) led to improved success rates with device implantation, reduced procedure time and less device size changes in comparison to standalone transesophageal echocardiogram (TEE) for left atrial appendage occlusion (LAAO) procedures.
Study Confirms Higher Accuracy of MRI Over Emerging PSMA PET/CT for Diagnosing Prostate Cancer
July 8th 2022Magnetic resonance imaging (MRI) had better accuracy than prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) “for detecting any grade of prostate cancer,” according to new study findings presented at the European Association of Urology Annual Congress (EAU22) in Amsterdam.
CMS Declines to Expand Coverage of Computed Tomography Colonography (CTC) for Medicare Beneficiaries
July 7th 2022Citing “insufficient” evidence, the Centers for Medicare and Medicaid Services (CMS) has declined a formal request by the American College of Radiology and multiple patient advocacy groups to reevaluate the lack of Medicare and Medicaid coverage of computed tomography colonography (CTC) for colorectal cancer screening.